CELLULARLINE S.P.A. financials
CELLULARLINE S.P.A.
8156008B8E5062681624 | Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Cost of sales | €93.2M | €98.4M |
| Gross profit | €63.4M | €65.8M |
| Distribution costs | €31.5M | €31.4M |
| Operating profit (EBIT) | -€37.9M | €8.0M |
| Finance costs | €3.3M | €5.7M |
| Profit before tax | -€38.0M | €6.2M |
| Income tax expense | -€1.7M | €593.0K |
| Profit for the year | -€36.3M | €5.6M |
| — attributable to owners | -€36.3M | €5.6M |
| — attributable to NCI | €0 | €0 |
| Total comprehensive income | -€36.1M | €5.3M |
| Per share | ||
| Basic EPS | €-1.74 | €0.26 |
| Diluted EPS | €-1.74 | €0.26 |
| Cash flow statement | ||
| Net cash from operating activities | €19.4M | €21.5M |
| Net cash from investing activities | -€5.6M | -€5.3M |
| Net cash from financing activities | -€10.9M | -€9.7M |
| Dividends paid | €1.9M | €1.8M |
| Net change in cash | €2.8M | €6.6M |
| Balance sheet | ||
| Total assets | €173.6M | €225.9M |
| Non-current assets | €52.7M | €99.0M |
| Property, plant & equipment | €6.8M | €7.5M |
| Right-of-use assets | €1.5M | €3.1M |
| Intangible assets & goodwill | €8.6M | €38.2M |
| Current assets | €120.9M | €126.9M |
| Trade & other receivables | €51.5M | €56.3M |
| Cash & equivalents | €23.6M | €20.8M |
| Total equity | €96.7M | €137.1M |
| — attributable to owners | €96.7M | €137.1M |
| Non-controlling interests | €0 | €0 |
| Non-current liabilities | €22.0M | €31.8M |
| Current liabilities | €54.9M | €57.1M |
| Current portion of long-term borrowings | €17.3M | €13.7M |
| Deferred tax liabilities | €770.0K | €1.4M |
| Derived metrics | ||
| Return on equity | -37.6% | 4.1% |
| Cash conversion ratio | -0.53× | 3.81× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | €2.6M | €5.1M |
| Adjustments For Decrease Increase In Trade Account Receivable | €5.2M | -€4.9M |
| Adjustments For Depreciation and Amortisation Expense | €55.9M | €13.7M |
| Adjustments For Finance Income Cost | €181.0K | €1.9M |
| Adjustments For Income Tax Expense | -€4.6M | -€3.0M |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -€50.0K | €0 |
| Adjustments For Increase Decrease In Trade Account Payable | -€2.2M | -€797.0K |
| Adjustments For Provisions | €1.1M | €2.3M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€76.0K | -€97.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €0 | €0 |
| Current Tax Assets Current | €609.0K | €294.0K |
| Current Tax Liabilities Current | €115.0K | €1.9M |
| Deferred Tax Assets | €10.0M | €6.4M |
| Disposals and Retirements Property Plant and Equipment | €5.6M | €5.3M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €1.0K | €146.0K |
| Equity and Liabilities | €173.6M | €225.9M |
| Finance Income | €2.5M | €3.8M |
| Financial Assets Held For Managing Liquidity Risk | €19.6M | €23.4M |
| Gains Losses On Exchange Differences On Translation Net of Tax | €226.0K | -€336.0K |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | €668.0K | €25.0K |
| General and Administrative Expense | €71.7M | €27.8M |
| Income Tax Relating To Components of Other Comprehensive Income | -€7.0K | -€2.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €1.7M | -€593.0K |
| Increase Decrease In Cash and Cash Equivalents | €2.8M | €6.7M |
| Intangible Assets Other Than Goodwill | €25.1M | €43.3M |
| Interest Paid Classified As Operating Activities | €181.0K | €1.9M |
| Inventories Total | €36.6M | €39.7M |
| Investments In Subsidiaries Joint Ventures and Associates | €504.0K | €428.0K |
| Issued Capital | €21.3M | €21.3M |
| Liabilities | €76.9M | €88.8M |
| Miscellaneous Other Operating Income | €1.8M | €1.5M |
| Noncurrent Portion of Other Noncurrent Borrowings | €14.2M | €21.1M |
| Noncurrent Provisions For Employee Benefits | €555.0K | €604.0K |
| Other Comprehensive Income | €243.0K | -€332.0K |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | €3.0K | €4.0K |
| Other Current Financial Assets | €366.0K | €341.0K |
| Other Current Financial Liabilities | €1.7M | €1.4M |
| Other Current Nonfinancial Assets | €8.2M | €9.6M |
| Other Current Nonfinancial Liabilities | €6.5M | €8.5M |
| Other Inflows Outflows of Cash Classified As Financing Activities | -€3.2M | -€3.9M |
| Other Inflows Outflows of Cash Classified As Operating Activities | -€570.0K | €3.0M |
| Other Longterm Provisions | €3.0M | €1.9M |
| Other Noncurrent Financial Liabilities | €3.5M | €6.8M |
| Other Noncurrent Nonfinancial Assets | €220.0K | €141.0K |
| Other Reserves | €104.4M | €104.7M |
| Retained Earnings | €7.3M | €5.3M |
| Revenue From Sale of Goods | €156.6M | €164.3M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | €76.0K | €97.0K |
| Trade and Other Current Payables To Trade Suppliers | €29.3M | €31.5M |
Every line item above is a fact tagged in CELLULARLINE S.P.A.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.